.

0 (hodnocen0 x )

EB

EB

ONLINE

Cham : Springer, 2017

1 online zdroj

ISBN 978-3-319-56827-0 (e-kniha)

ISBN 978-3-319-56825-6 (print)

02 Chapter 16. Treatment of Resistant Hypertension in the Light of New Guidelines: Drug Adherence -- Chapter 17. Treatment of Resistant Hypertension in the Light of New Guidelines: Pharmacological Approaches Using Multiple Drugs -- Chapter 18. Devices for Neural Modulation (Renal Denervation, Barostimulation) -- Chapter 19. The Effect of CPAP Therapy on Resistant Hypertension in Obstructive Sleep Apnea Syndrome Patients with Chronic Kidney Disease -- Chapter 20. Teaching Programs -- Chapter 21. Resistant Hypertension and the General Practitioner (Monitoring, Treatment).

This comprehensive volume provides a detailed review on the general work up of chronic kidney disease-associated resistant hypertension.  This title is separated into four parts; the first of which provides definitions, epidemiology, characteristics, risk stratification and outcomes of resistant and apparent treatment resistant hypertension.  The next two sections explore pathophysiology and diagnosis, treatment in the light of new guidelines, as well as procedures and devices for neural modulation.  Part four discusses public health approaches to resistant hypertension, educational programs, and resistant hypertension for general practitioners.  Resistant Hypertension in CKD brings up-to-date information to nephrologists, internists, cardiologists and a wide array of other clinicians and health professionals taking care of chronic kidney disease patients..

001475614

Chapter 1. Definitions of Resistant Hypertension and Epidemiology of Resistant Hypertension -- Chapter 2. Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: Epidemiological Data -- Chapter 3. Apparent Treatment-Resistant Hypertension and Chronic Kidney Disease: Another Cardiovascular-Renal Syndrome? -- Chapter 4. The Importance of Ambulatory and Home Monitoring Blood Pressure in Resistant Hypertension Associated with Chronic Kidney Disease -- Chapter 5. Resistant Hypertension and Outcomes in Patients With and Without Chronic Kidney Disease -- Chapter 6. Risk Stratification of Resistant Hypertension in Chronic Kidney Disease -- Chapter 7. Pathophysiological Insights in Resistant Hypertension -- Chapter 8. Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease -- Chapter 9. Secondary Causes: Work-up and Its Specificities in CKD, Which is the Most Common Identifiable Cause of Hypertension. I. Influence of Arterial Stiffening -- Chapter 10. Secondary Causes: Work-up and Its Specificities in CKD, Which Is the Most Common Identifiable Cause of Hypertension. II: Influence of Autonomic Dysfunction -- Chapter 11. Secondary Causes: Influence of Volume Overload, Especially in CKD Patients:  Excess Sodium Intake, Salt Retention in CKD -- Chapter 12. Resistant hypertension in elderly people with chronic kidney disease -- Chapter 13.  Obstructive Sleep Apnea and Resistant Hypertension -- Chapter 14. Interference with Pharmacological Agents to Resistant Hypertension in Chronic Kidney Disease -- Chapter 15. Public Health Efforts for Earlier Resistance Hypertension: Diagnosis, Reduction of Salt Content in Food, Promotion of the Use of Polypills to Facilitate Adherence, and Reimbursement Policies --